Waters is buying laboratory software developer Andrew Alliance having backed its 2018 series C round with fellow corporates Inpeco and Tecan.

Minsheng Life-backed oncology drug developer Zelgen has priced an initial public offering set to value it at more than $1.1bn.

Cigna's corporate venturing arm led a $29.5m round for population healthcare management platform Arcadia.io and bumped Buoy Health's series B up to $20m.

CareCentrix, Nationwide and existing backer Kaiser Permanente all chipped in as the homecare support services provider secured $30m.

Treadwell has launched with seed funding from Tio Bioventures to commercialise small molecule cancer drugs based on University Health Network research.

Abbott has returned for the first close of insulin technology developer Bigfoot Biomedical’s series C round, after backing its $55m series B two years ago.

Spectrum Health and HCA Healthcare both scored exits after medical analytics software provider Lumere was acquired by health software producer GHX.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Antiviral drug maker Gilead is among the investors that have backed the cell therapy startup’s $25m round.

Zipari has raised $22.5m from Horizon Healthcare Services and CareFirst BlueCross BlueShield among others to boost its total to $33.9m.